Authors:
Sahin, CA
Clewley, GS
Deayton, JR
Mocroft, A
Johnson, MA
Lee, CA
McLaughlin, JE
Griffiths, PD
Citation: Ca. Sahin et al., Shorter survival in HIV-positive patients with diarrhoea who excrete adenovirus from the GI tract, J MED VIROL, 58(3), 1999, pp. 280-285
Citation: Ic. Nitu et al., Management of liver failure in a haemophilic patient co-infected with human immunodeficiency and hepatitis C viruses, CLIN LAB H, 21(2), 1999, pp. 139-141
Authors:
Dragovich, PS
Prins, TJ
Zhou, R
Webber, SE
Marakovits, JT
Fuhrman, SA
Patick, AK
Matthews, DA
Lee, CA
Ford, CE
Burke, BJ
Rejto, PA
Hendrickson, TF
Tuntland, T
Brown, EL
Meador, JW
Ferre, RA
Harr, JEV
Kosa, MB
Worland, ST
Citation: Ps. Dragovich et al., Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P-1 lactam moieties as L-glutamine replacements, J MED CHEM, 42(7), 1999, pp. 1213-1224
Authors:
Davis, BJ
Lennard, DE
Lee, CA
Tiano, HF
Morham, SG
Wetsel, WC
Langenbach, R
Citation: Bj. Davis et al., Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E-2 and interleukin-1 beta, ENDOCRINOL, 140(6), 1999, pp. 2685-2695
Authors:
Wilde, JT
Lee, CA
Collins, P
Giangrande, PLF
Winter, M
Shiach, CR
Citation: Jt. Wilde et al., Increased bleeding associated with protease inhibitor therapy in HIV-positive patients with bleeding disorders, BR J HAEM, 107(3), 1999, pp. 556-559
Citation: Tt. Yee et al., Factor VIII inhibitors in haemophiliacs: a single-centre experience over 34 years, 1964-97, BR J HAEM, 104(4), 1999, pp. 909-914
Authors:
Sabin, CA
Devereux, H
Kinson, Z
Griffioen, A
Brown, D
Dusheiko, G
Lee, CA
Citation: Ca. Sabin et al., Effect of coinfection with hepatitis G virus on HIV disease progression inhemophilic men, J ACQ IMM D, 19(5), 1998, pp. 546-547
Citation: Ah. Miners et al., Assessing the effectiveness and cost-effectiveness of prophylaxis against bleeding in patients with severe haemophilia and severe von Willebrand's disease, J INTERN M, 244(6), 1998, pp. 515-522
Citation: Ic. Nitu et al., Clinical experience with the use of clotting factor concentrates in oral anticoagulation reversal, CLIN LAB H, 20(6), 1998, pp. 363-367
Authors:
Lee, CA
Lawrence, BP
Kerkvliet, NI
Rifkind, AB
Citation: Ca. Lee et al., 2,3,7,8-tetrachlorodibenzo-p-dioxin induction of cytochrome p450-dependentarachidonic acid metabolism in mouse liver microsomes: Evidence for species-specific differences in responses, TOX APPL PH, 153(1), 1998, pp. 1-11